Bone marrow contributions to fibrosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 7, 2013, Pages 955-961

  Mackinnon, Alison ^a   Forbes, Stuart ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bone marrow; Fibrocyte; Fibrosis; Macrophage; Myofibroblast

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COLLAGEN; CXCL16 CHEMOKINE;

ALLERGIC ASTHMA; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL TRACKING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; ENDOTHELIAL PROGENITOR CELL; FIBROSIS; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL; HEPATITIS C; HUMAN; LUNG FIBROSIS; MACROPHAGE; MESENCHYMAL STEM CELL; MONOCYTE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCLERODERMA; WOUND HEALING; ANIMAL;

MUS;

ANIMALS; BONE MARROW; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; FIBROSIS; HUMANS; MYOFIBROBLASTS;

EID: 84877083699     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.01.022     Document Type: Review

References (88)

1. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 2001, 166:7556-7562.
2. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., Belperio J.A., Keane M.P., Strieter R.M. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004, 114:438-446.
3. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 2006, 35:175-181.
4. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., Kaneko S. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:14098-14103.
5. Pilling D., Buckley C.D., Salmon M., Gomer R.H. Inhibition of fibrocyte differentiation by serum amyloid P. J. Immunol. 2003, 171:5537-5546.
6. Pilling D., Roife D., Wang M., Ronkainen S.D., Crawford J.R., Travis E.L., Gomer R.H. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J. Immunol. 2007, 179:4035-4044.
7. Murray L.A., Rosada R., Moreira A.P., Joshi A., Kramer M.S., Hesson D.P., Argentieri R.L., Mathai S., Gulati M., Herzog E.L., Hogaboam C.M. Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages. PLoS One 2010, 5:e9683.
8. Murray L.A., Kramer M.S., Hesson D.P., Watkins B.A., Fey E.G., Argentieri R.L., Shaheen F., Knight D.A., Sonis S.T. Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis. Fibrogenesis Tissue Repair 2010, 3:11.
9. Mathai S.K., Gulati M., Peng X., Russell T.R., Shaw A.C., Rubinowitz A.N., Murray L.A., Siner J.M., Antin-Ozerkis D.E., Montgomery R.R., Reilkoff R.A., Bucala R.J., Herzog E.L. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Investig. 2010, 90:812-823.
10. Kisseleva T., Brenner D.A. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J. Hepatol. 2012, 56:965-972.
11. Bernardo M.E., Locatelli F., Fibbe W.E. Mesenchymal stromal cells. Ann. N. Y. Acad. Sci. 2009, 1176:101-117.
12. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., Chen J.R., Chen Y.P., Lee O.K. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004, 40:1275-1284.
13. Nauta A.J., Kruisselbrink A.B., Lurvink E., Willemze R., Fibbe W.E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 2006, 177:2080-2087.
14. Stagg J., Galipeau J. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb. Exp. Pharmacol. 2007, 45-66.
15. Le Blanc K., Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 2012, 12:383-396.
16. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 2010, 5:e10088.
17. Rieger K., Marinets O., Fietz T., Korper S., Sommer D., Mucke C., Reufi B., Blau W.I., Thiel E., Knauf W.U. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp. Hematol. 2005, 33:605-611.
18. Dickhut A., Schwerdtfeger R., Kuklick L., Ritter M., Thiede C., Neubauer A., Brendel C. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Ann. Hematol. 2005, 84:722-727.
19. Franquesa M., Herrero E., Torras J., Ripoll E., Flaquer M., Goma M., Lloberas N., Anegon I., Cruzado J.M., Grinyo J.M., Herrero-Fresneda I. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 2012.
20. Guo J., Lin G.S., Bao C.Y., Hu Z.M., Hu M.Y. Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation 2007, 30:97-104.
21. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., Phinney D.G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8407-8411.
22. Zhao L., Feng Z., Hu B., Chi X., Jiao S. Ex vivo-expanded bone marrow mesenchymal stem cells facilitate recovery from chemically induced acute liver damage. Hepatogastroenterology 2012, 59.
23. Pitchford S.C., Furze R.C., Jones C.P., Wengner A.M., Rankin S.M. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009, 4:62-72.
24. Ciccocioppo R., Bernardo M.E., Sgarella A., Maccario R., Avanzini M.A., Ubezio C., Minelli A., Alvisi C., Vanoli A., Calliada F., Dionigi P., Perotti C., Locatelli F., Corazza G.R. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 2011, 60:788-798.
25. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., Ringden O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
26. D'Agostino B., Sullo N., Siniscalco D., De Angelis A., Rossi F. Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin. Biol. Ther. 2010, 10:681-687.
27. Jones C.P., Rankin S.M. Bone marrow-derived stem cells and respiratory disease. Chest 2011, 140:205-511.
28. Jujo K., Hamada H., Iwakura A., Thorne T., Sekiguchi H., Clarke T., Ito A., Misener S., Tanaka T., Klyachko E., Kobayashi K., Tongers J., Roncalli J., Tsurumi Y., Hagiwara N., Losordo D.W. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11008-11013.
29. Liu F., Liu Z.D., Wu N., Cong X., Fei R., Chen H.S., Wei L. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl. 2009, 15:1092-1100.
30. Sakamoto M., Nakamura T., Torimura T., Iwamoto H., Masuda H., Koga H., Abe M., Hashimoto O., Ueno T., Sata M. Transplantation of EPCs ameliorates vascular dysfunction and portal hypertension in CCl(4) -induced rat liver cirrhotic model. J. Gastroenterol. Hepatol. 2013.
31. Ma Y.Y., Sun D., Li J., Yin Z.C. Transplantation of endothelial progenitor cells alleviates renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Life Sci. 2010, 86:798-807.
32. Forbes S.J., Russo F.P., Rey V., Burra P., Rugge M., Wright N.A., Alison M.R. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004, 126:955-963.
33. Inagaki Y., Higashiyama R. Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis. Hepatol. Res. 2012, 42:543-548.
34. Kisseleva T., Uchinami H., Feirt N., Quintana-Bustamante O., Segovia J.C., Schwabe R.F., Brenner D.A. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 2006, 45:429-438.
35. Higashiyama R., Moro T., Nakao S., Mikami K., Fukumitsu H., Ueda Y., Ikeda K., Adachi E., Bou-Gharios G., Okazaki I., Inagaki Y. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 2009, 137:1459-1466. (e1).
36. Russo F.P., Alison M.R., Bigger B.W., Amofah E., Florou A., Amin F., Bou-Gharios G., Jeffery R., Iredale J.P., Forbes S.J. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006, 130:1807-1821.
37. Scholten D., Reichart D., Paik Y.H., Lindert J., Bhattacharya J., Glass C.K., Brenner D.A., Kisseleva T. Migration of fibrocytes in fibrogenic liver injury. Am. J. Pathol. 2011, 179:189-198.
38. Pilling D., Fan T., Huang D., Kaul B., Gomer R.H. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009, 4:e7475.
39. Schmidt M., Sun G., Stacey M.A., Mori L., Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 2003, 171:380-389.
40. Harris D.A., Zhao Y., Lapar D.J., Emaminia A., Steidle J.F., Stoler M., Linden J., Kron I.L., Lau C.L. Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model. J. Thorac. Cardiovasc. Surg. 2012.
41. Hashimoto N., Jin H., Liu T., Chensue S.W., Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 2004, 113:243-252.
42. Strieter R.M., Keeley E.C., Hughes M.A., Burdick M.D., Mehrad B. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol. 2009, 86:1111-1118.
43. Moeller A., Gilpin S.E., Ask K., Cox G., Cook D., Gauldie J., Margetts P.J., Farkas L., Dobranowski J., Boylan C., O'Byrne P.M., Strieter R.M., Kolb M. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009, 179:588-594.
44. Kotton D.N., Fabian A.J., Mulligan R.C. Failure of bone marrow to reconstitute lung epithelium. Am. J. Respir. Cell Mol. Biol. 2005, 33:328-334.
45. Moodley Y., Atienza D., Manuelpillai U., Samuel C.S., Tchongue J., Ilancheran S., Boyd R., Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am. J. Pathol. 2009, 175:303-313.
46. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., Valerius M.T., McMahon A.P., Duffield J.S. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 2010, 176:85-97.
47. Sakai N., Furuichi K., Shinozaki Y., Yamauchi H., Toyama T., Kitajima S., Okumura T., Kokubo S., Kobayashi M., Takasawa K., Takeda S., Yoshimura M., Kaneko S., Wada T. Fibrocytes are involved in the pathogenesis of human chronic kidney disease. Hum. Pathol. 2010, 41:672-678.
48. Chen G., Lin S.C., Chen J., He L., Dong F., Xu J., Han S., Du J., Entman M.L., Wang Y. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J. Am. Soc. Nephrol. 2011, 22:1876-1886.
49. Baba S., Fujii H., Hirose T., Yasuchika K., Azuma H., Hoppo T., Naito M., Machimoto T., Ikai I. Commitment of bone marrow cells to hepatic stellate cells in mouse. J. Hepatol. 2004, 40:255-260.
50. Sakaida I., Terai S., Yamamoto N., Aoyama K., Ishikawa T., Nishina H., Okita K. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004, 40:1304-1311.
51. Rabani V., Shahsavani M., Gharavi M., Piryaei A., Azhdari Z., Baharvand H. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol. Int. 2010, 34:601-605.
52. Carvalho A.B., Quintanilha L.F., Dias J.V., Paredes B.D., Mannheimer E.G., Carvalho F.G., Asensi K.D., Gutfilen B., Fonseca L.M., Resende C.M., Rezende G.F., Takiya C.M., de Carvalho A.C., Goldenberg R.C. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008, 26:1307-1314.
53. di Bonzo L.V., Ferrero I., Cravanzola C., Mareschi K., Rustichell D., Novo E., Sanavio F., Cannito S., Zamara E., Bertero M., Davit A., Francica S., Novelli F., Colombatto S., Fagioli F., Parola M. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008, 57:223-231.
54. Thomas J.A., Pope C., Wojtacha D., Robson A.J., Gordon-Walker T.T., Hartland S., Ramachandran P., Van Deemter M., Hume D.A., Iredale J.P., Forbes S.J. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 2011, 53:2003-2015.
55. Iwamoto T., Terai S., Hisanaga T., Takami T., Yamamoto N., Watanabe S., Sakaida I. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice. Cell Tissue Res. 2012.
56. Terai S., Ishikawa T., Omori K., Aoyama K., Marumoto Y., Urata Y., Yokoyama Y., Uchida K., Yamasaki T., Fujii Y., Okita K., Sakaida I. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006, 24:2292-2298.
57. Lin H., Zhang Z., Shi M., Xu R.N., Fu J.L., Geng H., Li Y.Y., Yu S.J., Chen L.M., Lv S., Wang F.S. Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi 2012, 20:487-491.
58. Zhang Z., Lin H., Shi M., Xu R., Fu J., Lv J., Chen L., Lv S., Li Y., Yu S., Geng H., Jin L., Lau G.K., Wang F.S. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J. Gastroenterol. Hepatol. 2012, 27(Suppl. 2):112-120.
59. Terai S., Sakaida I. Autologous bone marrow cell infusion therapy for liver cirrhosis patients. J. Hepatobiliary Pancreat. Sci. 2011, 18:23-25.
60. Watanabe T., Masamune A., Kikuta K., Hirota M., Kume K., Satoh K., Shimosegawa T. Bone marrow contributes to the population of pancreatic stellate cells in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297:G1138-G1146.
61. Akita S., Kubota K., Kobayashi A., Misawa R., Shimizu A., Nakata T., Yokoyama T., Takahashi M., Miyagawa S. Role of bone marrow cells in the development of pancreatic fibrosis in a rat model of pancreatitis induced by a choline-deficient/ethionine-supplemented diet. Biochem. Biophys. Res. Commun. 2012, 420:743-749.
62. Barth P.J., Ebrahimsade S., Hellinger A., Moll R., Ramaswamy A. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch. 2002, 440:128-133.
63. Direkze N.C., Forbes S.J., Brittan M., Hunt T., Jeffery R., Preston S.L., Poulsom R., Hodivala-Dilke K., Alison M.R., Wright N.A. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003, 21:514-520.
64. Higashiyama R., Nakao S., Shibusawa Y., Ishikawa O., Moro T., Mikami K., Fukumitsu H., Ueda Y., Minakawa K., Tabata Y., Bou-Gharios G., Inagaki Y. Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. J. Invest. Dermatol. 2011, 131:529-536.
65. Barisic-Dujmovic T., Boban I., Clark S.H. Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells. J. Cell. Physiol. 2010, 222:703-712.
66. Ortonne N., Lipsker D., Chantrel F., Boehm N., Grosshans E., Cribier B. Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br. J. Dermatol. 2004, 150:1050-1052.
67. Cowper S.E., Kuo P.H., Bucala R. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders. Arthritis Rheum. 2007, 56:3173-3175.
68. Galan A., Cowper S.E., Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr. Opin. Rheumatol. 2006, 18:614-617.
69. Delanian S., Martin M., Bravard A., Luccioni C., Lefaix J.L. Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage. Radiother. Oncol. 1998, 47:255-261.
70. Brittan M., Hunt T., Jeffery R., Poulsom R., Forbes S.J., Hodivala-Dilke K., Goldman J., Alison M.R., Wright N.A. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002, 50:752-757.
71. Lee C.Y., Jeffery R., Hutchinson G., Alison M.R., Poulsom R., Wright N.A., Otto W.R. Bone marrow cells in murine colitis: multi-signal analysis confirms pericryptal myofibroblast engraftment without epithelial involvement. PLoS One 2011, 6:e26082.
72. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
73. Gibbons M.A., MacKinnon A.C., Ramachandran P., Dhaliwal K., Duffin R., Phythian-Adams A.T., van Rooijen N., Haslett C., Howie S.E., Simpson A.J., Hirani N., Gauldie J., Iredale J.P., Sethi T., Forbes S.J. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 2011, 184:569-581.
74. Khalil N., Bereznay O., Sporn M., Greenberg A.H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 1989, 170:727-737.
75. Khalil N., Whitman C., Zuo L., Danielpour D., Greenberg A. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 1993, 92:1812-1818.
76. Rouhani F.N., Brantly M.L., Markello T.C., Helip-Wooley A., O'Brien K., Hess R., Huizing M., Gahl W.A., Gochuico B.R. Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. Am. J. Respir. Crit. Care Med. 2009, 180:1114-1121.
77. Direkze N.C., Hodivala-Dilke K., Jeffery R., Hunt T., Poulsom R., Oukrif D., Alison M.R., Wright N.A. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004, 64:8492-8495.
78. Dai L.J., Moniri M.R., Zeng Z.R., Zhou J.X., Rayat J., Warnock G.L. Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett. 2011, 305:8-20.
79. Khakoo A.Y., Pati S., Anderson S.A., Reid W., Elshal M.F., Rovira A.T., Nguyen D.Malide, Combs C.A., Hall G., Zhang J., Raffeld M., Rogers T.B., Stetler-Stevenson W., Frank J.A., Reitz M., Finkel T. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 2006, 203:1235-1247.
80. Qiao L., Xu Z., Zhao T., Zhao Z., Shi M., Zhao R.C., Ye L., Zhang X. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 2008, 18:500-507.
81. Loebinger M.R., Eddaoudi A., Davies D., Janes S.M. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res. 2009, 69:4134-4142.
82. Menon L.G., Picinich S., Koneru R., Gao H., Lin S.Y., Koneru M., Mayer-Kuckuk P., Glod J., Banerjee D. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007, 25:520-528.
83. Saunders R., Siddiqui S., Kaur D., Doe C., Sutcliffe A., Hollins F., Bradding P., Wardlaw A., Brightling C.E. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J. Allergy Clin. Immunol. 2009, 123:376-384.
84. Nunnari G., Vancheri C., Gilli E., Migliore S., Palermo F., La Rosa C., Nicotra P., Russo R., Cacopardo B. Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C. Front. Biosci. (Elite Ed) 2010, 2:1241-1245.
85. Sala E., Villena C., Balaguer C., Rios A., Fernandez-Palomeque C., Cosio B.G., Garcia J., Noguera A., Agusti A. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung 2010, 188:331-338.
86. Kaur S., Tripathi D., Dongre K., Garg V., Rooge S., Mukopadhyay A., Sakhuja P., Sarin S.K. Increased number and function of endothelial progenitor cells stimulate angiogenesis by resident liver sinusoidal endothelial cells (SECs) in cirrhosis through paracrine factors. J. Hepatol. 2012, 57:1193-1198.
87. Schiavon M., Fadini G.P., Lunardi F., Agostini C., Boscaro E., Calabrese F., Marulli G., Rea F. Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. J. Heart Lung Transplant. 2012, 31:1025-1030.
88. Asosingh K., Swaidani S., Aronica M., Erzurum S.C. Th1- and Th2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J. Immunol. 2007, 178:6482-6494.